516 related articles for article (PubMed ID: 21112167)
1. Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer.
Arndt T; Claussen U; Güssregen B; Schröfel S; Stürzer B; Werle A; Wolf G
Forensic Sci Int; 2011 May; 208(1-3):47-52. PubMed ID: 21112167
[TBL] [Abstract][Full Text] [Related]
2. Unintentional fatal intoxications with mitragynine and O-desmethyltramadol from the herbal blend Krypton.
Kronstrand R; Roman M; Thelander G; Eriksson A
J Anal Toxicol; 2011 May; 35(4):242-7. PubMed ID: 21513619
[TBL] [Abstract][Full Text] [Related]
3. Metabolism studies of the Kratom alkaloid speciociliatine, a diastereomer of the main alkaloid mitragynine, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
Anal Bioanal Chem; 2011 Mar; 399(8):2747-53. PubMed ID: 21249338
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of kratom or Krypton intake in urine using GC-MS in clinical and forensic toxicology.
Philipp AA; Meyer MR; Wissenbach DK; Weber AA; Zoerntlein SW; Zweipfenning PG; Maurer HH
Anal Bioanal Chem; 2011 Apr; 400(1):127-35. PubMed ID: 21153588
[TBL] [Abstract][Full Text] [Related]
5. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1049-55. PubMed ID: 21450536
[TBL] [Abstract][Full Text] [Related]
6. Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online.
Scott TM; Yeakel JK; Logan BK
Drug Test Anal; 2014 Sep; 6(9):959-63. PubMed ID: 24962931
[No Abstract] [Full Text] [Related]
7. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
[TBL] [Abstract][Full Text] [Related]
9. Analysis of mitragynine and metabolites in human urine for detecting the use of the psychoactive plant kratom.
Le D; Goggin MM; Janis GC
J Anal Toxicol; 2012; 36(9):616-25. PubMed ID: 23024321
[TBL] [Abstract][Full Text] [Related]
10. Patterns and reasons for kratom (Mitragyna speciosa) use among current and former opioid poly-drug users.
Singh D; Yeou Chear NJ; Narayanan S; Leon F; Sharma A; McCurdy CR; Avery BA; Balasingam V
J Ethnopharmacol; 2020 Mar; 249():112462. PubMed ID: 31816368
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry.
Sharma A; Kamble SH; León F; Chear NJ; King TI; Berthold EC; Ramanathan S; McCurdy CR; Avery BA
Drug Test Anal; 2019 Aug; 11(8):1162-1171. PubMed ID: 30997725
[TBL] [Abstract][Full Text] [Related]
12. Kratom (Mitragyna speciosa) Validation: Quantitative Analysis of Indole and Oxindole Alkaloids Reveals Chemotypes of Plants and Products.
Manwill PK; Flores-Bocanegra L; Khin M; Raja HA; Cech NB; Oberlies NH; Todd DA
Planta Med; 2022 Aug; 88(9-10):838-857. PubMed ID: 35468648
[TBL] [Abstract][Full Text] [Related]
13. Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".
Lesiak AD; Cody RB; Dane AJ; Musah RA
Forensic Sci Int; 2014 Sep; 242():210-218. PubMed ID: 25086346
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.
Warner ML; Kaufman NC; Grundmann O
Int J Legal Med; 2016 Jan; 130(1):127-38. PubMed ID: 26511390
[TBL] [Abstract][Full Text] [Related]
15. Use of liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry for studying the metabolism of paynantheine, an alkaloid of the herbal drug Kratom in rat and human urine.
Philipp AA; Wissenbach DK; Weber AA; Zapp J; Zoerntlein SW; Kanogsunthornrat J; Maurer HH
Anal Bioanal Chem; 2010 Apr; 396(7):2379-91. PubMed ID: 19902190
[TBL] [Abstract][Full Text] [Related]
16. Drug testing for mitragynine and kratom: Analytical challenges and medico-legal considerations.
Helander A; Rylski A
Drug Test Anal; 2023 Feb; 15(2):213-219. PubMed ID: 36258649
[TBL] [Abstract][Full Text] [Related]
17. Identification of five Mitragyna alkaloids in urine using liquid chromatography-quadrupole/time of flight mass spectrometry.
Basiliere S; Bryand K; Kerrigan S
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():11-19. PubMed ID: 29459087
[TBL] [Abstract][Full Text] [Related]
18. Testing for Kratom alkaloids in fingernail clippings - not only mitragynine.
Ameline A; Gheddar L; Arbouche N; Blanchot A; Raul JS; Kintz P
J Pharm Biomed Anal; 2024 Jun; 243():116078. PubMed ID: 38489958
[TBL] [Abstract][Full Text] [Related]
19. Development of indirect competitive ELISA for quantification of mitragynine in Kratom (Mitragyna speciosa (Roxb.) Korth.).
Limsuwanchote S; Wungsintaweekul J; Keawpradub N; Putalun W; Morimoto S; Tanaka H
Forensic Sci Int; 2014 Nov; 244():70-7. PubMed ID: 25216455
[TBL] [Abstract][Full Text] [Related]
20. Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna speciosa).
Kapp FG; Maurer HH; Auwärter V; Winkelmann M; Hermanns-Clausen M
J Med Toxicol; 2011 Sep; 7(3):227-31. PubMed ID: 21528385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
